Clinical Trials

BA-210 (also called Cethrin®): This study has been terminated (Product no longer will be developed by Alseres).   Trial can be joined between 0 and 72 hours after injury Countries: United ...

Nogo antibody (also called ATI355 or IN-1). Trial can be joined between 4 and 14 days after injury  Countries: Canada, Germany and Switzerland Asia A*: Complete injury Neurological ...

Anti-MAG (also called GSK249320). This study has been completed. Countries: USA, Germany and Australia Healthy subjects Company: GlaxoSmithKline A 1 dose intravenous therapy ...